Soleno Therapeutics, Inc
Photos
Soleno Therapeutics, Inc is a clinical-stage biopharmaceutical company based in Redwood City, CA. They are dedicated to developing and commercializing innovative therapeutics for the treatment of rare genetic disorders, with a particular focus on Prader-Willi syndrome (PWS). Their lead candidate, DCCR Diazoxide Choline Extended-Release tablets, is currently undergoing Phase 3 clinical trials for the treatment of PWS.
Driven by the needs of patients and their families, Soleno is committed to advancing research and providing new treatment options for those affected by rare diseases. Their mission is to improve the lives of patients living with complex and life-threatening conditions by developing safe and effective therapeutic products. Through their dedication to scientific innovation, Soleno aims to make a positive difference in the lives of patients and their families worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.